This inventor holds 1 USPTO granted patent. Top assignee: Shandong New Time Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Bin Li
Introduction
Bin Li is an accomplished inventor based in Linyi, Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments. His work focuses on utilizing bispecific antibodies to enhance therapeutic efficacy.
Latest Patents
Bin Li holds a patent for a groundbreaking invention titled "Method of Treatment Using a Bispecific Antibody Binding BCMA and CD3." This patent represents a significant advancement in the treatment of various diseases, showcasing his expertise and dedication to improving healthcare.
Career Highlights
Bin Li is currently employed at Shandong New Time Pharmaceutical Co., Ltd. His role at the company allows him to apply his innovative ideas and research to real-world applications. His contributions have been instrumental in the company's growth and success in the pharmaceutical industry.
Collaborations
Throughout his career, Bin Li has collaborated with talented individuals such as Zhenyu Li and Xingxia Hu. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of new solutions in the field of medicine.
Conclusion
Bin Li's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent and collaborations highlight his commitment to advancing medical treatments and improving patient outcomes. His contributions will undoubtedly have a lasting impact on the field.